Related Experiment Video
Updated: Aug 23, 2025

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
Risk Factors for Lung Function Decline in Pediatric Asthma under Treatment: A Retrospective, Multicenter,
Shingo Yamada1, Takao Fujisawa2, Mizuho Nagao1
1Allergy Center, National Hospital Organization Mie National Hospital, Tsu 514-0125, Japan.
Insights
Poor asthma control and long-acting beta2 agonist use are linked to declining lung function in children. Inhaled corticosteroid use, particularly at higher doses, is associated with better lung function trajectories in pediatric asthma patients.
Area of Science:
- Pediatric Pulmonology
- Asthma Research
- Lung Function Development
Background:
- Childhood asthma significantly impacts long-term lung function.
- Factors contributing to poor lung function during childhood asthma treatment remain unclear.
Purpose of the Study:
- To identify clinical factors associated with low or declining lung function in children undergoing asthma treatment.
- To analyze lung function trajectories from childhood through adolescence.
Main Methods:
- Longitudinal study of 273 children with asthma aged 6–15 years across seven Japanese hospitals.
- Evaluation of forced expiratory volume in 1 second (FEV1) % predicted values and linear regression slopes to define lung function trajectories (Normal, Low, Upward, Downward).
- Logistic regression analysis to compare factors associated with favorable (Normal/Upward) versus unfavorable (Low/Downward) lung function groups.
Main Results:
- 72% of patients showed favorable lung function trajectories (Normal/Upward), while 28% had unfavorable ones (Low/Downward).
- Unfavorable outcomes were linked to a history of poor asthma control, long-acting beta2 agonist use, and lower height Z-scores during adolescence.
- Favorable outcomes correlated with inhaled corticosteroid (ICS) use during pre-adolescence and high-dose ICS use during adolescence.
Conclusions:
- Several clinical factors predict lung function trajectories in pediatric asthma.
- Monitoring asthma control, ICS dosage, and long-acting beta2 agonist use is crucial for managing pediatric lung function.
- Early and consistent ICS treatment may be key to maintaining optimal lung function in children with asthma.
Abstract:
Background: Childhood asthma is a major risk for low lung function in later adulthood, but what factors in asthma are associated with the poor lung function during childhood is not known. Objective: To identify clinical factors in children with asthma associated with low or declining lung function during the treatment. Methods: We enrolled children with asthma who had been treated throughout three age periods, i.e., 6−9, 10−12, and 13−15 years old, at seven specialized hospitals in Japan. Clinical information and lung function measurements were retrieved from the electronic chart systems. To characterize the lung function trajectories during each age period, we evaluated the forced expiratory volume 1 (FEV1) with % predicted values and individual changes by the slope (S) from linear regression. We defined four trajectory patterns: normal (Group N) and low (Group L), showing %FEV1 ≥80% or <80% throughout all three periods; upward (Group U) and downward (Group D), showing S ≥ 0 or S < 0%. Logistic regression analysis was performed to compare factors associated with the unfavorable (D/L) versus favorable (N/U) groups. Results: Among 273 eligible patients, 197 (72%) were classified into Group N (n = 150)/U (n = 47), while 76 (28%) were in Group D (n = 66)/L (n = 10). A history of poor asthma control, long-acting beta2 agonist use, and a lower height Z-score during 13−15 years were associated with an unfavorable outcome (Group D/L). Conversely, inhaled corticosteroid (ICS) use during 10−12 years and high-dose ICS use during 13−15 years were associated with a favorable outcome (Group N/U). Conclusion: We identified several factors that are associated with unfavorable lung function changes in pediatric asthma. Attention should be paid to the possible relationship between yearly changes in lung function and poor asthma control, use of ICS (and its dose) and use of LABA.
Related Concept Videos
Asthma-I: Introduction
Asthma-III: Symptoms and Complications
Classification of Asthma
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.

